Template:COVID-19: Difference between revisions

Jump to navigation Jump to search
No edit summary
No edit summary
 
(25 intermediate revisions by 6 users not shown)
Line 1: Line 1:
{| class="infobox bordered" style="width: 15em; text-align: left; font-size: 90%; background:AliceBlue"
{| class="infobox bordered" style="width: 20em; text-align: left; font-size: 80%; background:AliceBlue"
|-
|-
| colspan="1" style="text-align:center; background:DarkGray" |
| colspan="1" style="text-align:center; background:DarkGray" |


'''COVID-19 Microchapters'''
'''COVID-19 Microchapters'''
|- bgcolor="LightGrey"
|- bgcolor="LightGrey"
!
!
Line 10: Line 11:
!
!
[[COVID-19|Home]]
[[COVID-19|Home]]
|-
!
|- bgcolor="Pink"
!
[[Long COVID|Long COVID]]
|-
!
|- bgcolor="Pink"
!
[[COVID-19 frequently asked outpatient questions|Frequently Asked Outpatient Questions]]
|-
!
|- bgcolor="Pink"
!
[[COVID-19 frequently asked inpatient questions|Frequently Asked Inpatient Questions]]
|-  
|-  
!
!
Line 42: Line 60:
|-  
|-  
!
!
|- bgcolor="Pink"
|- bgcolor="Pink"
!
!
Line 179: Line 196:
|-  
|-  
!  
!  
|- bgcolor="PaleTurquoise"
|- bgcolor="PaleTurquoise"
!
!
[[COVID-19 secondary prevention|Secondary Prevention]]
[[COVID-19 vaccines|Vaccines]]
|-  
|-  
!  
!  
|- bgcolor="PaleTurquoise"
|- bgcolor="PaleTurquoise"
!
!
[[COVID-19 cost-effectiveness of therapy|Cost-Effectiveness of Therapy]]
[[COVID-19 secondary prevention|Secondary Prevention]]
|-  
|-  
!  
!  
|- bgcolor="PaleTurquoise"
|- bgcolor="PaleTurquoise"
!
!
[[COVID-19 future or investigational therapies|Future or Investigational Therapies]]
[[COVID-19 future or investigational therapies|Future or Investigational Therapies]]
:[[COVID-19 future or investigational therapies#Ongoing Clinical Trials|Ongoing Clinical Trials]]
|-  
|-  
!
!

Latest revision as of 13:59, 9 March 2022